Dashboard
1
The company has declared Negative results for the last 9 consecutive quarters
- NET PROFIT(HY) At CNY 29.14 MM has Grown at -93.08%
- INTEREST(HY) At CNY 44.12 MM has Grown at 64.19%
- OPERATING CASH FLOW(Y) Lowest at CNY 839.48 MM
2
With ROE of -1.38%, it has a risky valuation with a 1.77 Price to Book Value
Stock DNA
Specialty Chemicals
CNY 29,583 Million (Large Cap)
NA (Loss Making)
NA
1.24%
0.15
-0.75%
2.71
Revenue and Profits:
Net Sales:
1,978 Million
(Quarterly Results - Dec 2025)
Net Profit:
435 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.13%
0%
-8.13%
6 Months
124.58%
0%
124.58%
1 Year
123.39%
0%
123.39%
2 Years
141.77%
0%
141.77%
3 Years
-5.09%
0%
-5.09%
4 Years
-34.55%
0%
-34.55%
5 Years
74.84%
0%
74.84%
Canmax Technologies Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
39.27%
EBIT Growth (5y)
-184.71%
EBIT to Interest (avg)
45.52
Debt to EBITDA (avg)
0.55
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.60
Tax Ratio
18.27%
Dividend Payout Ratio
58.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.38%
ROE (avg)
36.70%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.77
EV to EBIT
-145.32
EV to EBITDA
47.19
EV to Capital Employed
1.69
EV to Sales
3.23
PEG Ratio
NA
Dividend Yield
1.93%
ROCE (Latest)
-1.16%
ROE (Latest)
-1.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
1,977.90
2,113.10
-6.40%
Operating Profit (PBDIT) excl Other Income
486.30
285.60
70.27%
Interest
27.90
21.00
32.86%
Exceptional Items
1.60
0.60
166.67%
Consolidate Net Profit
434.90
186.20
133.57%
Operating Profit Margin (Excl OI)
172.30%
66.30%
10.60%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -6.40% vs 19.37% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 133.57% vs 203.33% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7,538.10
6,597.60
14.26%
Operating Profit (PBDIT) excl Other Income
913.30
1,212.20
-24.66%
Interest
97.50
76.40
27.62%
Exceptional Items
-19.00
-67.60
71.89%
Consolidate Net Profit
448.20
1,004.80
-55.39%
Operating Profit Margin (Excl OI)
43.80%
109.40%
-6.56%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 14.26% vs -36.76% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -55.39% vs -52.53% in Dec 2024
About Canmax Technologies Co., Ltd. 
Canmax Technologies Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






